{
    "root": "a1d5849f-265f-4c95-8511-580dac1bc900",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "ZOLPIDEM TARTRATE",
    "value": "20250515",
    "ingredients": [
        {
            "name": "CI 77491",
            "code": "1K09F3G675"
        },
        {
            "name": "ZOLPIDEM TARTRATE",
            "code": "WY6W63843K",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_10126"
        }
    ],
    "indications": {
        "text": "zolpidem tartrate tablets , usp gamma-amino butyric acid ( gaba ) receptor positive modulator , indicated short-term treatment insomnia characterized difficulties sleep initiation .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "lowest dose effective patient must exceed total 10 mg daily ( 2.1 ) treatment short possible ( 2.1 ) recommended initial dose single dose 5 mg women single dose 5 10 mg men , immediately bedtime least 7 8 hours remaining planned time awakening ( 2.1 ) geriatric patients patients mild moderate hepatic impairment : recommended dose 5 mg men women ( 2.2 ) lower doses cns depressants may necessary taken concomitantly zolpidem tartrate tablets ( 2.3 ) effect zolpidem tartrate tablets may slowed taken immediately meal ( 2.4 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "product : 50090-1022 product : 50090-1023 ndc : 50090-1023-0 10 tablet bottle ndc : 50090-1023-1 30 tablet bottle",
    "adverseReactions": "patients experienced complex sleep behaviors taking zolpidem tartrate tablets ( 4 ) known hypersensitivity zolpidem ( 4 )",
    "indications_original": "Zolpidem tartrate tablets, USP a gamma-amino butyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation.",
    "contraindications_original": "Use the lowest dose effective for the patient and must not exceed a total of 10 mg daily ( 2.1 ) Treatment should be as short as possible ( 2.1 ) Recommended initial dose is a single dose of 5 mg for women and a single dose of 5 or 10 mg for men, immediately before bedtime with at least 7 to 8 hours remaining before the planned time of awakening ( 2.1 ) Geriatric patients and patients with mild to moderate hepatic impairment: Recommended dose is 5 mg for men and women ( 2.2 ) Lower doses of CNS depressants may be necessary when taken concomitantly with zolpidem tartrate tablets ( 2.3 ) The effect of zolpidem tartrate tablets may be slowed if taken with or immediately after a meal ( 2.4 )",
    "warningsAndPrecautions_original": "Product:    50090-1022\n                  Product:    50090-1023\n                  NDC:    50090-1023-0   10 TABLET in a BOTTLE\n                  NDC:    50090-1023-1   30 TABLET in a BOTTLE",
    "adverseReactions_original": "Patients who have experienced complex sleep behaviors after taking zolpidem tartrate tablets ( 4 ) Known hypersensitivity to zolpidem ( 4 )",
    "drug": [
        {
            "name": "ZOLPIDEM TARTRATE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_10126"
        }
    ]
}